We developed a strong predictive model using a large, retrospective database to distinguish risk of VTE in obese pregnant women, which may provide the foundation for future protocol development of obstetrical thromboprophylaxis in obese women.
OBJECTIVE: Vascular assessment of the retinal choroidal layer of pregnant women's eyes may serve as a noninvasive surrogate measure of placental perfusion. Previous research has reported conflicting data about the changes in the choroidal layer in healthy pregnancies. Chronic systemic vascular diseases such as hypertension and diabetes have been associated with decreased subfoveal choroidal thickness (SFCT) in nonpregnant adults, but the effect of these conditions have not been reported in pregnant women. Thus, the purpose of our study was to examine the subfoveal choroidal thickness (SFCT) in pregnant women with preexisting vascular disease. STUDY DESIGN: This prospective study included 67 pregnant women in the third trimester with indications for antenatal testing (ANT). SFCT measurements were collected using the Heidelberg optical coherence tomography angiography machine and measured using Spectralis software. Multivariable linear regression analyses were performed to determine correlations between maternal disease and the choroidal thickness. RESULTS: 67 women had both eyes imaged for a total of 134 SFCT values. 13% had chronic hypertension (CHTN), 9% had gestational hypertension (GHTN), 21% had gestational diabetes (GDM), 4% had type 2 diabetes mellitus (T2DM), and 54% were of advanced maternal age (AMA).
In this study cohort, pregnant women with CHTN or T2DM or both had significantly decreased mean SFCT (209um vs 245um, p¼0.008). However, having GDM or GHTN was not significantly correlated with decreased SFCT. Additionally, in a population of AMA patients, having any chronic disease was significantly negatively correlated with decreased mean SFCT values (199um vs 251um, p¼0.0003). CONCLUSION: In this study we found a significant association between chronic vascular disease and decreased SFCT in pregnant women. This same result was not seen for vascular disease with new onset in pregnancy, regardless of maternal age. Future studies are planned to determine whether decreased SFCT, presumably caused by arteriolar sclerosis, can be used as a biomarker to predict adverse pregnancy outcomes associated with ischemic placental disease.
861 The effects of Body Mass Index on pregnancy outcomes: a systematic review and meta-analysis 
OBJECTIVE:
To determine the effect of body mass index (BMI) on pregnancy outcomes STUDY DESIGN: We searched Medline, Embase, PubMed, www. clinicaltrials.gov and the Cochrane databases from inception until June 2017 for all experimental and observational studies reporting on pregnancy outcomes in women with BMI >30 using appropriate MeSH terms and keywords. Title/abstract screening and data extraction was performed in duplicate. As all identified studies were observational, risk of bias assessment was performed using the Newcastle Ottawa Scale for observational studies. Random-effects meta-analysis was used to calculate incidences and 95% confidence intervals (CI) for maternal and fetal/neonatal outcomes, stratified by BMI category. Relative risks (RR) for each outcome were similarly calculated over those for women with normal BMI. RESULTS: 5328 studies were identified, of which 19 representing 1,499,238 women were included in the descriptive analysis and 16 in the meta-analysis. All studies had a low risk of bias. Almost all maternal and fetal complications increased with each BMI class. The pregnancy risks with BMI>40 over those of normal BMI were as follows: hypertensive disorders of pregnancy (16.1% vs. 2.8%, RR 5.8 (4.4, 7.8 
